<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Clinical manifestations and diagnosis of candidemia and invasive candidiasis in adults</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Clinical manifestations and diagnosis of candidemia and invasive candidiasis in adults</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Clinical manifestations and diagnosis of candidemia and invasive candidiasis in adults</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Carol A Kauffman, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John W Baddley, MD, MSPH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Keri K Hall, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> May 11, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The term candidemia describes the presence of <em>Candida</em> species in the blood. <em>Candida</em> in a blood culture should never be viewed as a contaminant and should always prompt a search for the source. In all cases, candidemia requires treatment with an antifungal agent; it should never be assumed that removal of a catheter alone is adequate therapy for candidemia. (See  <a class="medical medical_review" href="/z/d/html/2430.html" rel="external">"Management of candidemia and invasive candidiasis in adults"</a>.)</p><p>Clinical issues related to the clinical manifestations and diagnosis of candidemia will be reviewed here. The epidemiology, pathogenesis, and treatment of candidemia are discussed separately. <em>Candida</em> endocarditis; hepatosplenic candidiasis (chronic disseminated candidiasis); <em>Candida</em> endophthalmitis; <em>Candida </em>infections of the central nervous system, bladder, and kidneys; empiric treatment of presumed invasive candidiasis; and an overview of <em>Candida</em> infections are also presented elsewhere. (See  <a class="medical medical_review" href="/z/d/html/2442.html" rel="external">"Candidemia in adults: Epidemiology, microbiology, and pathogenesis"</a> and  <a class="medical medical_review" href="/z/d/html/2430.html" rel="external">"Management of candidemia and invasive candidiasis in adults"</a> and  <a class="medical medical_review" href="/z/d/html/2423.html" rel="external">"Candida endocarditis and suppurative thrombophlebitis"</a> and  <a class="medical medical_review" href="/z/d/html/2425.html" rel="external">"Chronic disseminated candidiasis (hepatosplenic candidiasis)"</a> and  <a class="medical medical_review" href="/z/d/html/2446.html" rel="external">"Treatment of endogenous endophthalmitis and chorioretinitis due to Candida species"</a> and  <a class="medical medical_review" href="/z/d/html/2453.html" rel="external">"Candida infections of the central nervous system"</a> and  <a class="medical medical_review" href="/z/d/html/2415.html" rel="external">"Candida infections of the bladder and kidneys"</a> and  <a class="medical medical_review" href="/z/d/html/2416.html" rel="external">"Overview of Candida infections"</a>.)</p><p>Candidemia in neonates and children is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/5028.html" rel="external">"Epidemiology and risk factors for Candida infection in neonates"</a> and  <a class="medical medical_review" href="/z/d/html/5024.html" rel="external">"Clinical manifestations and diagnosis of Candida infection in neonates"</a> and  <a class="medical medical_review" href="/z/d/html/5029.html" rel="external">"Treatment of Candida infection in neonates"</a> and  <a class="medical medical_review" href="/z/d/html/5042.html" rel="external">"Prevention of Candida infection in neonates"</a> and  <a class="medical medical_review" href="/z/d/html/5976.html" rel="external">"Candidemia and invasive candidiasis in children: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/5972.html" rel="external">"Candida infections in children"</a> and  <a class="medical medical_review" href="/z/d/html/6014.html" rel="external">"Candidemia and invasive candidiasis in children: Management"</a>.)</p><p class="headingAnchor" id="H668928547"><span class="h1">CLASSIFICATION</span><span class="headingEndMark"> — </span>Candidemia may be only the most obvious manifestation of invasive infection with <em>Candida </em>species. Some experts have proposed dividing invasive <em>Candida</em> infections into three subgroups: candidemia without deep-seated or visceral involvement, candidemia with deep-seated or visceral <em>Candida</em> infection, and deep-seated (visceral) candidiasis without candidemia [<a href="#rid1">1</a>]. In at least one study, each entity was responsible for approximately one-third of cases [<a href="#rid2">2</a>]. The diagnosis of invasive candidiasis is made most easily in those patients with positive blood cultures, but the low sensitivity of blood cultures means that some patients with deep-seated infection may be missed. More rapid techniques for identifying yeasts in blood cultures and refinement of non–culture-based techniques are active areas of investigation. (See <a class="local">'Diagnosis'</a> below.)</p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Candidiasis is an increasingly important nosocomial infection. Although <em>Candida albicans</em> is the most common cause of candidemia, there has been increased isolation of non-albicans species of <em>Candida</em> in recent years. Patients in the intensive care unit and those who are immunocompromised are most at risk for the development of candidemia.</p><p>The epidemiology of and risk factors for candidemia are discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/2442.html" rel="external">"Candidemia in adults: Epidemiology, microbiology, and pathogenesis"</a>.)</p><p class="headingAnchor" id="H3"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>The clinical manifestations of candidemia vary from minimal fever to a full-blown sepsis syndrome that resembles severe bacterial infection. Invasive candidiasis is defined by hematogenous spread to multiple viscera (eg, eye, kidney, heart valves, brain).</p><p>Clinical clues on physical examination that point to possible hematogenous spread of <em>Candida</em> include characteristic eye lesions (chorioretinitis with or without vitritis), skin lesions, and, much less commonly, muscle abscesses.</p><p>The frequency of eye lesions in patients with candidemia is variable. Early studies found that more than 20 percent of cases of candidemia had associated eye lesions; subsequent estimates are closer to 2 percent, with few cases of vitritis [<a href="#rid3">3</a>]. This discrepancy may be attributable to timing of examination; in the setting of early involvement, only chorioretinitis may be present. These issues are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/16953.html" rel="external">"Epidemiology, clinical manifestations, and diagnosis of fungal endophthalmitis", section on 'Epidemiology and risk factors'</a>.)</p><p>Skin lesions tend to appear suddenly as clusters of painless pustules on an erythematous base; they can occur on any area of the body. The lesions vary from tiny pustules that can be easily missed (<a class="graphic graphic_picture graphicRef55977" href="/z/d/graphic/55977.html" rel="external">picture 1</a>) to others that are nodular, several centimeters in diameter, and appear necrotic in the center (<a class="graphic graphic_picture graphicRef75717" href="/z/d/graphic/75717.html" rel="external">picture 2</a>). In severely neutropenic patients, the lesions may be macular rather than pustular. In patients with negative blood cultures, the recognition of these lesions as a manifestation of candidemia and subsequent punch biopsy may lead to the diagnosis. (See <a class="local">'Diagnosis'</a> below.)</p><p>Less commonly, patients describe soreness in a discrete muscle group caused by <em>Candida</em> microabscesses. Examination reveals a tender muscle that may be warm and swollen (<a class="graphic graphic_picture graphicRef64945" href="/z/d/graphic/64945.html" rel="external">picture 3</a>).</p><p>In addition to these typical peripheral sites of involvement, signs of multiorgan system failure may be present due to involvement of the kidneys, heart, liver, spleen, lungs, eyes, and brain (<a class="graphic graphic_picture graphicRef52139" href="/z/d/graphic/52139.html" rel="external">picture 4</a>).</p><p>Other manifestations of invasive candidiasis and approach to empiric treatment are discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/2416.html" rel="external">"Overview of Candida infections"</a> and  <a class="medical medical_review" href="/z/d/html/16953.html" rel="external">"Epidemiology, clinical manifestations, and diagnosis of fungal endophthalmitis"</a> and  <a class="medical medical_review" href="/z/d/html/2453.html" rel="external">"Candida infections of the central nervous system"</a> and  <a class="medical medical_review" href="/z/d/html/2466.html" rel="external">"Candida osteoarticular infections"</a> and  <a class="medical medical_review" href="/z/d/html/2423.html" rel="external">"Candida endocarditis and suppurative thrombophlebitis"</a> and  <a class="medical medical_review" href="/z/d/html/2425.html" rel="external">"Chronic disseminated candidiasis (hepatosplenic candidiasis)"</a> and  <a class="medical medical_review" href="/z/d/html/2430.html" rel="external">"Management of candidemia and invasive candidiasis in adults"</a>.)</p><p class="headingAnchor" id="H4"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>The gold standard for the diagnosis of invasive candidiasis and candidemia is a positive culture. Blood cultures should be obtained in all patients with suspected candidemia. Not infrequently, patients will have blood cultures drawn without a specific concern for <em>Candida</em> infection, and then diagnosis is made when the cultures yield <em>Candida</em> species. In patients with focal findings (eg, skin lesions or parenchymal involvement), biopsy should be performed for staining, culture, and histopathologic evaluation. Non-culture-based methods are used increasingly to aid in the diagnosis of invasive <em>Candida </em>infections for which blood cultures often are negative. (See <a class="local">'Nonculture methods'</a> below.)</p><p class="headingAnchor" id="H13881850"><span class="h2">Culture and stain of biopsy material</span><span class="headingEndMark"> — </span>Directed biopsy of sites of involvement often leads to a definitive diagnosis. Material obtained by scraping the base of a pustule should be submitted to the microbiology laboratory for Gram stain (<a class="graphic graphic_picture graphicRef70812" href="/z/d/graphic/70812.html" rel="external">picture 5</a>) and culture. More commonly, a punch biopsy is performed and the tissue is submitted for culture and for histopathologic examination using special stains for fungi.</p><p>Punch biopsies of skin or tissue biopsy will show microabscesses, and special stains will show budding yeasts and often pseudohyphae or hyphae that are characteristic of <em>Candida</em> species.</p><p class="headingAnchor" id="H5"><span class="h2">Blood cultures</span><span class="headingEndMark"> — </span>The most straightforward method to detect candidemia is to grow the organism from the blood; however, in one study, blood cultures were positive in only approximately 50 percent of patients found to have disseminated candidiasis at autopsy [<a href="#rid1">1</a>]. </p><p>There have been many studies comparing the sensitivity of different blood culture systems for the detection of yeasts [<a href="#rid4">4,5</a>]. The introduction of the lysis-centrifugation method (Isolator tube) improved the detection of yeasts when compared with other blood culture systems. Subsequent changes in the culture media used in the BACTEC and BactiAlert systems, allowing enhanced growth of yeasts, have made these systems as sensitive as the lysis-centrifugation technique for detecting <em>Candida</em> species in blood.</p><p>A drawback of all blood culture systems for the diagnosis of candidemia is that one to three days are required for growth and an additional one to two days for identification of the organism after subculture onto agar medium. For a seriously ill patient, more rapid and more sensitive techniques are essential.</p><p>Several techniques have been developed that decrease the time to identification of the most common <em>Candida</em> species once a blood culture bottle shows growth and yeasts are seen on the smear of the bottle contents. Using the technique of peptide nucleic acid fluorescence in situ hybridization (PNA-FISH), <em>C. albicans</em> and <em>Candida glabrata </em>can be identified within hours of a blood culture becoming positive for yeast [<a href="#rid6">6,7</a>].</p><p>Another technique is matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). Using this technique, proteins released from <em>Candida</em> spp are detected and compared with a large database of proteins from many species of yeast [<a href="#rid8">8</a>]. MALDI-TOF MS is performed on colonies that have grown from a blood culture bottle, and results can be read in as short a period as 30 minutes.</p><p>The emerging species <em>Candida auris</em> requires specialized methods for identification, and it could therefore be misidentified as another yeast (most commonly <em>Candida haemulonii</em> but also <em>Candida famata</em>, <em>Candida sake</em>, <em>Candida catenulata</em>, unspecified <em>Candida</em> species, <em>Rhodotorula glutinis</em>, <em>Saccharomyces cerevisiae</em>) when using traditional biochemical methods [<a href="#rid9">9</a>]. A MALDI-TOF MS assay is available for the identification of <em>C. auris</em> [<a href="#rid10">10</a>]. (See  <a class="medical medical_review" href="/z/d/html/2442.html" rel="external">"Candidemia in adults: Epidemiology, microbiology, and pathogenesis", section on 'C. auris emergence'</a>.)</p><p>A study that compared the performance of blood cultures with the polymerase chain reaction (PCR) and the beta-D-glucan assay is discussed below. (See <a class="local">'Polymerase chain reaction'</a> below.)</p><p class="headingAnchor" id="H7"><span class="h2">Nonculture methods</span><span class="headingEndMark"> — </span>Over the last several decades, substantial efforts have been directed at the development of non-culture-based method for the diagnosis of candidemia [<a href="#rid11">11</a>].</p><p class="headingAnchor" id="H9"><span class="h3">Beta-D-glucan assay</span><span class="headingEndMark"> — </span>The beta-D-glucan assay has proven useful for diagnosis of invasive candidiasis [<a href="#rid12">12</a>]. However, beta-D-glucan is present in the cell wall of many fungi and is not specific for <em>Candida</em> [<a href="#rid13">13-17</a>]. Additionally, false positive beta-D-glucan tests have been noted following intravenous therapy with immunoglobulins and albumin, in the presence of gauze packing materials used in surgery, and with disruption of gut integrity that can occur with chemotherapy-induced mucositis, in the presence of septic shock, and with intestinal ischemia [<a href="#rid18">18</a>]. Therefore, the beta-D-glucan assay should not be used as a definitive test for diagnosis of invasive candidiasis; its interpretation should be guided by clinical and microbiologic data. In the appropriate clinical circumstances, the assay can be useful for detection of deep-seated invasive candidiasis (eg, intra-abdominal candidiasis) when blood cultures are negative [<a href="#rid19">19</a>].</p><p>Consistent with a high sensitivity but low specificity, a negative beta-D-glucan test has high negative predictable value and has been shown to be sufficient to guide discontinuation of empiric antifungal therapy in the intensive care unit setting [<a href="#rid18">18,20,21</a>]. (See  <a class="medical medical_review" href="/z/d/html/1613.html" rel="external">"Evaluation and management of suspected sepsis and septic shock in adults", section on 'Choosing a regimen'</a>.)</p><p>In one systematic review including 10 studies, the sensitivity and specificity of beta-D-glucan were 81 and 60 percent, respectively [<a href="#rid17">17</a>]. In an earlier study including 107 patients who had proven candidiasis, between 78 and 81 percent had positive beta-D-glucan assay results (depending on the chosen cutoff for a positive result) [<a href="#rid14">14</a>]. A subsequent Japanese autopsy series that included 41 patients with invasive fungal infection who had a beta-D-glucan assay performed noted positive and negative predictive values of 70 and 98 percent, respectively (using a cut-off of 60 picograms/mL) [<a href="#rid15">15</a>]. </p><p>Use of blood cultures together with a beta-D-glucan assay or polymerase chain reaction has been associated with higher diagnostic sensitivity than blood cultures alone [<a href="#rid22">22</a>]. This is discussed further below. (See <a class="local">'Polymerase chain reaction'</a> below.)</p><p class="headingAnchor" id="H3499818720"><span class="h3">T2Candida</span><span class="headingEndMark"> — </span>In 2014, the US Food and Drug Administration (FDA) cleared the T2Candida panel and T2Dx instrument (T2Candida) for the detection of bloodstream infection caused by <em>C. albicans</em>, <em>Candida tropicalis</em>, <em>Candida parapsilosis</em>, and <em>C. glabrata</em>/<em>Candida krusei</em>. The T2Candida assay can detect as few as 1 to 3 colony-forming units/mL from a blood specimen within three to five hours, far more quickly than blood cultures. The assay breaks yeast cells apart, releasing deoxyribonucleic acid (DNA); copies the target DNA; and detects the amplified DNA using magnetic resonance technology. This technology enhances the early detection of candidemia [<a href="#rid23">23</a>].</p><p>In a study that included 1801 patients, T2Candida had an overall sensitivity of 91 percent and correctly categorized nearly 100 percent of negative specimens as negative for the presence of yeast [<a href="#rid24">24</a>].</p><p>In a multicenter study of 152 patients with candidemia detected by blood cultures, follow-up blood samples were collected for T2Candida testing and repeat blood cultures [<a href="#rid25">25</a>]. Median time between collection of diagnostic blood cultures and follow-up specimens was 56 hours (range 16 to 148 hours). The T2Candida assay was positive in 69 of 152 patients (45 percent), whereas follow-up blood cultures were positive in 36 of 152 patients (24 percent). T2Candida sensitivity was 89 percent as positive results were obtained in 32 of 36 patients with positive cultures. The presence of an antifungal reduced the sensitivity of the T2 assay but to a lesser amount than that seen for blood cultures; in 112 patients who were already receiving antifungal therapy, the T2Candida assay was positive in 56 (50 percent) but blood cultures were positive in only 24 (21 percent). </p><p class="headingAnchor" id="H11"><span class="h3">Polymerase chain reaction</span><span class="headingEndMark"> — </span>One current focus of non-culture methods is on the development of a PCR assay for candidemia and invasive candidiasis [<a href="#rid26">26</a>]. For the detection of candidemia, the sensitivity of PCR has been previously reported to be similar to that of blood cultures [<a href="#rid27">27-29</a>] and, in occasional cases of invasive candidiasis, PCR has assisted in establishing the diagnosis when cultures were negative [<a href="#rid27">27</a>]. The main drawback is that no PCR assay has been standardized and none are routinely available.</p><p>A study compared the performance of a real-time PCR assay, the beta-D-glucan assay, and blood cultures for diagnosing invasive candidiasis in 55 patients with invasive candidiasis (17 with candidemia, 33 with deep-seated candidiasis, and 5 with both) and 73 hospitalized controls [<a href="#rid22">22</a>]. The PCR assay was more sensitive than the beta-D-glucan assay for diagnosing invasive candidiasis (80 versus 56 percent) but had comparable specificity (70 versus 73 percent). The PCR assay and the beta-D-glucan assay had similar sensitivity for candidemia, but PCR was more sensitive for deep-seated candidiasis (89 versus 53 percent). Both PCR and the beta-D-glucan assay were more sensitive than blood cultures among patients who had invasive candidiasis. In patients with invasive candidiasis, the sensitivity of blood cultures combined with PCR or the beta-D-glucan assay was 98 and 79 percent, respectively. Thus, these two non–culture-based assays, when combined with blood cultures, have the potential to increase the sensitivity of culture methods for invasive candidiasis.</p><p class="headingAnchor" id="H3499818714"><span class="h3">Antibody assays</span><span class="headingEndMark"> — </span>To date, no sensitive and specific <em>Candida</em> antibody assay has been developed that is useful for diagnosis. Because <em>Candida</em> are part of the normal microbiota, healthy persons have antibodies against these organisms, thereby decreasing the specificity of the assay. Additionally, an immunosuppressed host may be unable to generate a vigorous antibody response to <em>Candida</em> infection, thereby decreasing the sensitivity of the assay in this high-risk population.</p><p class="headingAnchor" id="H3296164222"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/104270.html" rel="external">"Society guideline links: Candidiasis"</a>.)</p><p class="headingAnchor" id="H12"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Significance of positive blood culture</strong> – <em>Candida</em> in a blood culture should never be viewed as a contaminant and should always prompt a search for the source. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition and symptoms of candidemia</strong> – Candidemia is defined as the presence of <em>Candida</em> spp in the bloodstream. The clinical manifestations of candidemia vary from minimal fever to a full-blown sepsis syndrome that is indistinguishable from severe bacterial infection. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition and symptoms of invasive candidiasis</strong> – Invasive candidiasis is defined as hematogenous spread to multiple viscera (eg, eye, kidney, heart valves, brain). A positive blood culture for <em>Candida </em>spp is not necessary to make the diagnosis of invasive candidiasis. (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1">Clinical clues on physical examination to hematogenous spread of<em> Candida</em> include characteristic eye lesions (chorioretinitis with or without vitritis), skin lesions, and, much less commonly, muscle abscesses. (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – The gold standard for the diagnosis of candidemia is a blood culture growing <em>Candida</em> spp; blood cultures should be obtained in all patients with suspected candidemia. However, blood cultures can be negative in patients with invasive candidiasis, and the diagnosis in such cases is often based on clinical suspicion. (See <a class="local">'Blood cultures'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Role of biopsy</strong> – In patients with focal findings (eg, skin lesions or parenchymal involvement), biopsy should be performed for staining, culture, and histopathologic evaluation. (See <a class="local">'Diagnosis'</a> above and <a class="local">'Culture and stain of biopsy material'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Role of beta-D-glucan</strong> – When available, we suggest obtaining a beta-D-glucan assay as an adjunct to blood cultures and biopsy. It appears to be particularly useful in patients with deep-seated candidiasis (eg, intra-abdominal candidiasis), given the low sensitivity of blood cultures in this setting. However, beta-D-glucan is present in the cell wall of many fungi, and there are other non-fungal causes of false-positive beta-D-glucan tests; therefore, this assay is not specific for <em>Candida</em> spp. (See <a class="local">'Diagnosis'</a> above and <a class="local">'Beta-D-glucan assay'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Clancy CJ, Nguyen MH. Finding the "missing 50%" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clin Infect Dis 2013; 56:1284.</a></li><li><a class="nounderline abstract_t">Leroy O, Gangneux JP, Montravers P, et al. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Crit Care Med 2009; 37:1612.</a></li><li><a class="nounderline abstract_t">Oude Lashof AM, Rothova A, Sobel JD, et al. Ocular manifestations of candidemia. Clin Infect Dis 2011; 53:262.</a></li><li><a class="nounderline abstract_t">Wilson ML, Davis TE, Mirrett S, et al. Controlled comparison of the BACTEC high-blood-volume fungal medium, BACTEC Plus 26 aerobic blood culture bottle, and 10-milliliter isolator blood culture system for detection of fungemia and bacteremia. J Clin Microbiol 1993; 31:865.</a></li><li><a class="nounderline abstract_t">Muñoz P, Bernaldo de Quirós JC, Berenguer J, et al. Impact of the BACTEC NR system in detecting Candida fungemia. J Clin Microbiol 1990; 28:639.</a></li><li><a class="nounderline abstract_t">Gherna M, Merz WG. Identification of Candida albicans and Candida glabrata within 1.5 hours directly from positive blood culture bottles with a shortened peptide nucleic acid fluorescence in situ hybridization protocol. J Clin Microbiol 2009; 47:247.</a></li><li><a class="nounderline abstract_t">Shepard JR, Addison RM, Alexander BD, et al. Multicenter evaluation of the Candida albicans/Candida glabrata peptide nucleic acid fluorescent in situ hybridization method for simultaneous dual-color identification of C. albicans and C. glabrata directly from blood culture bottles. J Clin Microbiol 2008; 46:50.</a></li><li><a class="nounderline abstract_t">Spanu T, Posteraro B, Fiori B, et al. Direct maldi-tof mass spectrometry assay of blood culture broths for rapid identification of Candida species causing bloodstream infections: an observational study in two large microbiology laboratories. J Clin Microbiol 2012; 50:176.</a></li><li><a class="nounderline abstract_t">Jeffery-Smith A, Taori SK, Schelenz S, et al. Candida auris: a Review of the Literature. Clin Microbiol Rev 2018; 31.</a></li><li class="breakAll">US Food and Drug Administration. FDA News Release. FDA authorizes new use of test, first to identify the emerging pathogen Candida aurisFDA News Release. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm605336.htm (Accessed on August 22, 2018).</li><li><a class="nounderline abstract_t">Clancy CJ, Nguyen MH. Diagnosing Invasive Candidiasis. J Clin Microbiol 2018; 56.</a></li><li><a class="nounderline abstract_t">Reiss E, Obayashi T, Orle K, et al. Non-culture based diagnostic tests for mycotic infections. Med Mycol 2000; 38 Suppl 1:147.</a></li><li><a class="nounderline abstract_t">Odabasi Z, Mattiuzzi G, Estey E, et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004; 39:199.</a></li><li><a class="nounderline abstract_t">Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. Multicenter clinical evaluation of the (1--&gt;3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005; 41:654.</a></li><li><a class="nounderline abstract_t">Obayashi T, Negishi K, Suzuki T, Funata N. Reappraisal of the serum (1--&gt;3)-beta-D-glucan assay for the diagnosis of invasive fungal infections--a study based on autopsy cases from 6 years. Clin Infect Dis 2008; 46:1864.</a></li><li><a class="nounderline abstract_t">Mohr JF, Sims C, Paetznick V, et al. Prospective survey of (1→3)-beta-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting. J Clin Microbiol 2011; 49:58.</a></li><li><a class="nounderline abstract_t">Hage CA, Carmona EM, Epelbaum O, et al. Microbiological Laboratory Testing in the Diagnosis of Fungal Infections in Pulmonary and Critical Care Practice. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med 2019; 200:535.</a></li><li><a class="nounderline abstract_t">Finkelman MA. Specificity Influences in (1→3)-β-d-Glucan-Supported Diagnosis of Invasive Fungal Disease. J Fungi (Basel) 2020; 7.</a></li><li><a class="nounderline abstract_t">Tissot F, Lamoth F, Hauser PM, et al. β-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis. Am J Respir Crit Care Med 2013; 188:1100.</a></li><li><a class="nounderline abstract_t">Pappas PG, Kauffman CA, Andes DR, et al. Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis 2016; 62:409.</a></li><li><a class="nounderline abstract_t">Dupuis C, Le Bihan C, Maubon D, et al. Performance of Repeated Measures of (1-3)-β-D-Glucan, Mannan Antigen, and Antimannan Antibodies for the Diagnosis of Invasive Candidiasis in ICU Patients: A Preplanned Ancillary Analysis of the EMPIRICUS Randomized Clinical Trial. Open Forum Infect Dis 2021; 8:ofab080.</a></li><li><a class="nounderline abstract_t">Nguyen MH, Wissel MC, Shields RK, et al. Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. Clin Infect Dis 2012; 54:1240.</a></li><li><a class="nounderline abstract_t">Clancy CJ, Nguyen MH. T2 magnetic resonance for the diagnosis of bloodstream infections: charting a path forward. J Antimicrob Chemother 2018; 73:iv2.</a></li><li><a class="nounderline abstract_t">Mylonakis E, Clancy CJ, Ostrosky-Zeichner L, et al. T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial. Clin Infect Dis 2015; 60:892.</a></li><li><a class="nounderline abstract_t">Clancy CJ, Pappas PG, Vazquez J, et al. Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida Panel. Clin Infect Dis 2018; 66:1678.</a></li><li><a class="nounderline abstract_t">Kourkoumpetis TK, Fuchs BB, Coleman JJ, et al. Polymerase chain reaction-based assays for the diagnosis of invasive fungal infections. Clin Infect Dis 2012; 54:1322.</a></li><li><a class="nounderline abstract_t">Ahmad S, Khan Z, Mustafa AS, Khan ZU. Seminested PCR for diagnosis of candidemia: comparison with culture, antigen detection, and biochemical methods for species identification. J Clin Microbiol 2002; 40:2483.</a></li><li><a class="nounderline abstract_t">McMullan R, Metwally L, Coyle PV, et al. A prospective clinical trial of a real-time polymerase chain reaction assay for the diagnosis of candidemia in nonneutropenic, critically ill adults. Clin Infect Dis 2008; 46:890.</a></li><li><a class="nounderline abstract_t">Lau A, Halliday C, Chen SC, et al. Comparison of whole blood, serum, and plasma for early detection of candidemia by multiplex-tandem PCR. J Clin Microbiol 2010; 48:811.</a></li></ol></div><div id="topicVersionRevision">Topic 2462 Version 29.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23315320" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Finding the "missing 50%" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19325476" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21765074" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Ocular manifestations of candidemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8463399" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Controlled comparison of the BACTEC high-blood-volume fungal medium, BACTEC Plus 26 aerobic blood culture bottle, and 10-milliliter isolator blood culture system for detection of fungemia and bacteremia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2324285" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Impact of the BACTEC NR system in detecting Candida fungemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18987173" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Identification of Candida albicans and Candida glabrata within 1.5 hours directly from positive blood culture bottles with a shortened peptide nucleic acid fluorescence in situ hybridization protocol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17977998" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Multicenter evaluation of the Candida albicans/Candida glabrata peptide nucleic acid fluorescent in situ hybridization method for simultaneous dual-color identification of C. albicans and C. glabrata directly from blood culture bottles.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22090401" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Direct maldi-tof mass spectrometry assay of blood culture broths for rapid identification of Candida species causing bloodstream infections: an observational study in two large microbiology laboratories.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29142078" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Candida auris: a Review of the Literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29142078" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Candida auris: a Review of the Literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29444828" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Diagnosing Invasive Candidiasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11204140" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Non-culture based diagnostic tests for mycotic infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15307029" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16080087" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Multicenter clinical evaluation of the (1--&gt;3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18462174" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Reappraisal of the serum (1--&gt;3)-beta-D-glucan assay for the diagnosis of invasive fungal infections--a study based on autopsy cases from 6 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21048005" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Prospective survey of (1→3)-beta-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31469325" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Microbiological Laboratory Testing in the Diagnosis of Fungal Infections in Pulmonary and Critical Care Practice. An Official American Thoracic Society Clinical Practice Guideline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33383818" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Specificity Influences in (1→3)-β-d-Glucan-Supported Diagnosis of Invasive Fungal Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23782027" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : β-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26810419" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33816643" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Performance of Repeated Measures of (1-3)-β-D-Glucan, Mannan Antigen, and Antimannan Antibodies for the Diagnosis of Invasive Candidiasis in ICU Patients: A Preplanned Ancillary Analysis of the EMPIRICUS Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22431804" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Performance of Candida real-time polymerase chain reaction,β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29608754" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : T2 magnetic resonance for the diagnosis of bloodstream infections: charting a path forward.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25586686" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29438475" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida Panel.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22362884" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Polymerase chain reaction-based assays for the diagnosis of invasive fungal infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12089267" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Seminested PCR for diagnosis of candidemia: comparison with culture, antigen detection, and biochemical methods for species identification.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18260751" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : A prospective clinical trial of a real-time polymerase chain reaction assay for the diagnosis of candidemia in nonneutropenic, critically ill adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20042634" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Comparison of whole blood, serum, and plasma for early detection of candidemia by multiplex-tandem PCR.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
